James Colson - AstraZeneca Global Account Manager

With over 20 years of experience in logistics, James has principally worked in the European road sector, including both own account and third party. More recently, this has expanded to air and ocean environments too, with a focus on healthcare solutions for pharmaceutical customers. James' in-depth knowledge has led to him heading up the internal Yusen team that is focused on Brexit, and the impacts and implications for both Yusen and our customers.

Recent Posts

The wider impacts of Brexit in the UK

Posted by James Colson - AstraZeneca Global Account Manager on 08-Jan-2019 09:27:00
Show Bio

Why it’s not just logistics supply chains that directly trade between the UK and the EU that will be affected

In the UK, we have already seen the uncertainty leading up to the Brexit withdrawal date impacting the financial markets and the value of the GBP.  In fact, since the results of the referendum, the value of the pound has taken a hit that it is yet to recover from. 

  

The laborious withdrawal process has been fraught with delays and setbacks which still today, with just 3 months to go, have failed to be resolved. So, what does this mean for the UK?

Read More
0 Comments

Topics: Brexit, Logistics, Supply Chain Management, Freight transportation

Improving logistics management:  preventing drug shortages through better visibility

Posted by James Colson - AstraZeneca Global Account Manager on 01-Nov-2018 10:24:00
Show Bio

Our previous blogs considered the causes of healthcare supply chain failures, which often result in product losses due to breaches in compliance.   Within logistics, minimising product losses will help contribute to reducing drug shortages overall – not just for the pharmaceuticals associated within a particular shipment but for the resource associated with replacing lost product too, which could have been spent elsewhere in the business. 

Read More
0 Comments

Topics: Healthcare logistics

Preparing for Brexit: The key potential scenarios for your supply chain

Posted by James Colson - AstraZeneca Global Account Manager on 03-May-2018 11:45:29
Show Bio

 

 
 As we get closer to the final date for officially leaving the EU, a more defined future for our industries will become clear.

For now, however, we still have some time before the end of the ‘leave’ transitional phase of December 2020, and the fine details are still far from clear. At Yusen, our focus must be on potential scenarios, expected outcomes and comprehensive logistics contingency planning, for both ourselves and our customers.

Read More
0 Comments

Topics: Brexit, Supply Chain Management

Make a comment

Follow Us

Subscribe to Email Updates

Recent Posts

Posts by Topic

see all